Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Mar 14, 2011
Financial News
Theratechnologies withdraws follow-on
...3/8/11 Type: Follow-on Underwriters: Jefferies; Stifel Nicolaus Weisel; RBC Capital Markets; BMO Capital Markets; Desjardins;
NBF Securities Corp.
...
Read More
BioCentury
|
Feb 28, 2011
Financial News
Theratechnologies proposes follow-on
...Price prior: C$4.81 Underwriters: Jefferies; Stifel Nicolaus Weisel; RBC Capital Markets; BMO Capital Markets; Desjardins;
NBF Securities Corp.
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Mar 14, 2011
Financial News
Theratechnologies withdraws follow-on
...3/8/11 Type: Follow-on Underwriters: Jefferies; Stifel Nicolaus Weisel; RBC Capital Markets; BMO Capital Markets; Desjardins;
NBF Securities Corp.
...
Read More
BioCentury
|
Feb 28, 2011
Financial News
Theratechnologies proposes follow-on
...Price prior: C$4.81 Underwriters: Jefferies; Stifel Nicolaus Weisel; RBC Capital Markets; BMO Capital Markets; Desjardins;
NBF Securities Corp.
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page